Loading...
Header Logo
Keywords
Last Name
Institution

Dr Uche Amazigo

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Onyeneho NG, Amazigo UV, Njepuome NA, Nwaorgu OC, Okeibunor JC. Perception and utilization of public health services in Southeast Nigeria: Implication for health care in communities with different degrees of urbanization. Int J Equity Health. 2016 Jan 20; 15:12. PMID: 26791575.
      View in: PubMed
    2. Krotneva SP, Coffeng LE, Noma M, Zouré HG, Bakoné L, Amazigo UV, de Vlas SJ, Stolk WA. African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases. PLoS Negl Trop Dis. 2015; 9(9):e0004051. PMID: 26401658.
      View in: PubMed
    3. Brieger WR, Sommerfeld JU, Amazigo UV. The Potential for Community-Directed Interventions: Reaching Underserved Populations in Africa. Int Q Community Health Educ. 2015; 35(4):295-316. PMID: 26470395.
      View in: PubMed
    4. Zouré HG, Noma M, Tekle AH, Amazigo UV, Diggle PJ, Giorgi E, Remme JH. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected. Parasit Vectors. 2014 Jul 22; 7:326. PMID: 25053392.
      View in: PubMed
    5. Coffeng LE, Stolk WA, Zouré HG, Veerman JL, Agblewonu KB, Murdoch ME, Noma M, Fobi G, Richardus JH, Bundy DA, Habbema D, de Vlas SJ, Amazigo UV. African programme for onchocerciasis control 1995-2015: updated health impact estimates based on new disability weights. PLoS Negl Trop Dis. 2014 Jun; 8(6):e2759. PMID: 24901642.
      View in: PubMed
    6. Coffeng LE, Stolk WA, Zouré HG, Veerman JL, Agblewonu KB, Murdoch ME, Noma M, Fobi G, Richardus JH, Bundy DA, Habbema D, de Vlas SJ, Amazigo UV. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost. PLoS Negl Trop Dis. 2013; 7(1):e2032. PMID: 23383355.
      View in: PubMed
    7. Allotey P, Amazigo U, Adjei S, Seddoh A, Lusamba-Dikassa PS. 15 years of APOC--a lifetime of public health evidence. Lancet. 2012 Oct 20; 380(9851):1361-3. PMID: 23084441.
      View in: PubMed
    8. Okeibunor J, Bump J, Zouré HG, Sékétéli A, Godin C, Amazigo UV. A model for evaluating the sustainability of community-directed treatment with ivermectin in the African Program for Onchocerciasis Control. Int J Health Plann Manage. 2012 Jul-Sep; 27(3):257-71. PMID: 22711222.
      View in: PubMed
    9. Brieger WR, Okeibunor JC, Abiose AO, Ndyomugyenyi R, Wanji S, Elhassan E, Amazigo UV. Characteristics of persons who complied with and failed to comply with annual ivermectin treatment. Trop Med Int Health. 2012 Jul; 17(7):920-30. PMID: 22575028.
      View in: PubMed
    10. Meredith SE, Cross C, Amazigo UV. Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda. Health Res Policy Syst. 2012 May 10; 10:16. PMID: 22574885.
      View in: PubMed
    11. Tchounkeu YF, Onyeneho NG, Wanji S, Kabali AT, Manianga C, Amazigo UV, Amuyunzu-Nyamongo M. Changes in stigma and discrimination of onchocerciasis in Africa. Trans R Soc Trop Med Hyg. 2012 Jun; 106(6):340-7. PMID: 22513165.
      View in: PubMed
    12. Amazigo UV, Leak SG, Zoure HG, Njepuome N, Lusamba-Dikassa PS. Community-driven interventions can revolutionise control of neglected tropical diseases. Trends Parasitol. 2012 Jun; 28(6):231-8. PMID: 22503153.
      View in: PubMed
    13. Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S, Abiose A, Remme JH. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors. 2012 Feb 07; 5:28. PMID: 22313631.
      View in: PubMed
    14. Okeibunor JC, Brieger WR, Abiose AO, Elhassan E, Ndyomugyenyi R, Wanji S, Amazigo UV. Intention to continue with ivermectin treatment for onchocerciasis control after eight years of annual distribution in Cameroon, Nigeria, and Uganda. Int Q Community Health Educ. 2012-2013; 33(2):159-73. PMID: 23661417.
      View in: PubMed
    15. Brieger WR, Okeibunor JC, Abiose AO, Wanji S, Elhassan E, Ndyomugyenyi R, Amazigo UV. Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria. Parasit Vectors. 2011 Jul 27; 4:152. PMID: 21794139.
      View in: PubMed
    16. Zouré HG, Wanji S, Noma M, Amazigo UV, Diggle PJ, Tekle AH, Remme JH. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLoS Negl Trop Dis. 2011 Jun; 5(6):e1210. PMID: 21738809.
      View in: PubMed
    17. Amuyunzu-Nyamongo M, Tchounkeu YF, Oyugi RA, Kabali AT, Okeibunor JC, Manianga C, Amazigo UV. Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa. Int J Qual Stud Health Well-being. 2011; 6(2). PMID: 21637349.
      View in: PubMed
    18. Ozoh GA, Murdoch ME, Bissek AC, Hagan M, Ogbuagu K, Shamad M, Braide EI, Boussinesq M, Noma MM, Murdoch IE, Sékétéli A, Amazigo UV. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease. Trop Med Int Health. 2011 Jul; 16(7):875-83. PMID: 21481109.
      View in: PubMed
    19. Tekle AH, Zoure H, Wanji S, Leak S, Noma M, Remme JH, Amazigo U. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies. Acta Trop. 2011 Sep; 120 Suppl 1:S81-90. PMID: 20525531.
      View in: PubMed
    20. Garms R, Lakwo TL, Ndyomugyenyi R, Kipp W, Rubaale T, Tukesiga E, Katamanywa J, Post RJ, Amazigo UV. The elimination of the vector Simulium neavei from the Itwara onchocerciasis focus in Uganda by ground larviciding. Acta Trop. 2009 Sep; 111(3):203-10. PMID: 19446785.
      View in: PubMed
    21. Traoré S, Wilson MD, Sima A, Barro T, Diallo A, Aké A, Coulibaly S, Cheke RA, Meyer RR, Mas J, McCall PJ, Post RJ, Zouré H, Noma M, Yaméogo L, Sékétéli AV, Amazigo UV. The elimination of the onchocerciasis vector from the island of Bioko as a result of larviciding by the WHO African Programme for Onchocerciasis Control. Acta Trop. 2009 Sep; 111(3):211-8. PMID: 19619686.
      View in: PubMed
    22. Amazigo U. The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2008 Sep; 102 Suppl 1:19-22. PMID: 18718149.
      View in: PubMed
    23. Amazigo U. Engaging the community: an interview with Uche Amazigo by Brown Hannah. PLoS Negl Trop Dis. 2008 Jul 30; 2(7):e268. PMID: 18665270.
      View in: PubMed
    24. Emukah EC, Enyinnaya U, Olaniran NS, Akpan EA, Hopkins DR, Miri ES, Amazigo U, Okoronkwo C, Stanley A, Rakers L, Richards FO, Katabarwa MN. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria. Ann Trop Med Parasitol. 2008 Jan; 102(1):45-51. PMID: 18186977.
      View in: PubMed
    25. Remme JH, Amazigo U, Engels D, Barryson A, Yameogo L. Efficacy of ivermectin against Onchocerca volvulus in Ghana. Lancet. 2007 Sep 29; 370(9593):1123-4; author reply 1124-5. PMID: 17905154.
      View in: PubMed
    26. Amazigo U, Okeibunor J, Matovu V, Zouré H, Bump J, Seketeli A. Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci Med. 2007 May; 64(10):2070-82. PMID: 17383061.
      View in: PubMed
    27. Brieger WR, Okeibunor JC, Abiose AO, Ndyomugyenyi R, Kisoka W, Wanji S, Elhassan E, Amazigo UV. Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control. Trop Med Int Health. 2007 Feb; 12(2):260-8. PMID: 17300634.
      View in: PubMed
    28. Amazigo U, Boatin B. The future of onchocerciasis control in Africa. Lancet. 2006 Dec 02; 368(9551):1946-7. PMID: 17141687.
      View in: PubMed
    29. Okeibunor JC, Abiose A, Onwujekwe OE, Mohamed NA, Adekeye O, Ogungbemi MK, Amazigo UV. The rapid monitoring of ivermectin treatment: will school-based surveys provide the answer? Ann Trop Med Parasitol. 2005 Dec; 99(8):771-9. PMID: 16297290.
      View in: PubMed
    30. Maduka CU, Nweke LN, Miri ES, Amazigo U, Emukah EC, Richards FO. Missed treatment opportunities, for pregnant and breast-feeding women, in onchocerciasis mass-treatment programmes in south-eastern Nigeria. Ann Trop Med Parasitol. 2004 Oct; 98(7):697-702. PMID: 15509423.
      View in: PubMed
    31. Amazigo UV, Nnoruka E, Maduka C, Bump J, Benton B, Sékétéli A. Ivermectin improves the skin condition and self-esteem of females with onchocerciasis: a report of two cases. Ann Trop Med Parasitol. 2004 Jul; 98(5):533-7. PMID: 15257804.
      View in: PubMed
    32. Emukah EC, Osuoha E, Miri ES, Onyenama J, Amazigo U, Obijuru C, Osuji N, Ekeanyanwu J, Amadiegwu S, Korve K, Richards FO. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria. Am J Trop Med Hyg. 2004 May; 70(5):556-61. PMID: 15155991.
      View in: PubMed
    33. Sama MT, Homeida M, Ngang P, Liese BH, Amazigo U, Seketeli A. A multi-centre study of community-directed ivermectin distributors' (CDDs') involvement in other healthcare and development programme activities in Cameroon, Togo, Sudan, Nigeria and Uganda. Trop Doct. 2003 Oct; 33(4):237-41. PMID: 14620432.
      View in: PubMed
    34. Sékétéli A, Adeoye G, Eyamba A, Nnoruka E, Drameh P, Amazigo UV, Noma M, Agboton F, Aholou Y, Kale OO, Dadzie KY. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002 Mar; 96 Suppl 1:S15-28. PMID: 12081247.
      View in: PubMed
    35. Noma M, Nwoke BE, Nutall I, Tambala PA, Enyong P, Namsenmo A, Remme J, Amazigo UV, Kale OO, Sékétéli A. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002 Mar; 96 Suppl 1:S29-39. PMID: 12081248.
      View in: PubMed
    36. Amazigo UV, Obono M, Dadzie KY, Remme J, Jiya J, Ndyomugyenyi R, Roungou JB, Noma M, Sékétéli A. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002 Mar; 96 Suppl 1:S75-92. PMID: 12081253.
      View in: PubMed
    37. Amazigo UV, Brieger WR, Katabarwa M, Akogun O, Ntep M, Boatin B, N'Doyo J, Noma M, Sékétéli A. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002 Mar; 96 Suppl 1:S41-58. PMID: 12081250.
      View in: PubMed
    38. Clemmons L, Amazigo UV, Bissek AC, Noma M, Oyene U, Ekpo U, Msuya-Mpanju J, Katenga S, Sékétéli A. Gender issues in the community-directed treatment with ivermectin (CDTI) of the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2002 Mar; 96 Suppl 1:S59-74. PMID: 12081252.
      View in: PubMed
    39. Homeida M, Braide E, Elhassan E, Amazigo UV, Liese B, Benton B, Noma M, Etya'alé D, Dadzie KY, Kale OO, Sékétéli A. APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control. Ann Trop Med Parasitol. 2002 Mar; 96 Suppl 1:S93-104. PMID: 12081254.
      View in: PubMed
    40. Iroegbu CU, Ene-Obong HN, Uwaegbute AC, Amazigo UV. Bacteriological quality of weaning food and drinking water given to children of market women in Nigeria: implications for control of diarrhoea. J Health Popul Nutr. 2000 Dec; 18(3):157-62. PMID: 11262769.
      View in: PubMed
    41. Nwaorgu OC, Okeibunor J, Madu E, Amazigo U, Onyegegbu N, Evans D. A school-based schistosomiasis and intestinal helminthiasis control programme in Nigeria: acceptability to community members. Trop Med Int Health. 1998 Oct; 3(10):842-9. PMID: 9809919.
      View in: PubMed
    42. Ene-Obong HN, Uwaegbute AC, Iroegbu CU, Amazigo UV. The effect of two child-care practices of market women on diarrhoea prevalence, feeding patterns and nutritional status of children aged 0-24 months. J Diarrhoeal Dis Res. 1998 Sep; 16(3):173-9. PMID: 9919014.
      View in: PubMed
    43. Amazigo U, Noma M, Boatin BA, Etya'alé DE, Sékétéli A, Dadzie KY. Delivery systems and cost recovery in Mectizan treatment for onchocerciasis. Ann Trop Med Parasitol. 1998 Apr; 92 Suppl 1:S23-31. PMID: 9861264.
      View in: PubMed
    44. Amazigo U. Onchocerciasis and women's reproductive health: indigenous and biomedical concepts. Trop Doct. 1993 Oct; 23(4):149-51. PMID: 8273155.
      View in: PubMed
    Amazigo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description